Busato, Davide
Capolla, Sara
Durigutto, Paolo
Mossenta, Monica
Bozzer, Sara
Sblattero, Daniele
Macor, Paolo
Dal Bo, Michele http://orcid.org/0000-0001-8668-7621
Toffoli, Giuseppe
Funding for this research was provided by:
PNRR - M4C2-I1.3 (PE_00000019 "HEAL ITALIA)
Article History
Received: 6 October 2023
Accepted: 20 November 2023
First Online: 28 November 2023
Declarations
:
: The animal experimental protocol for <i>in-vivo</i> studies was approved by the Italian Ministry of Health (No. 788/2015- PR).
: Not applicable.
: DB, SC, PM, MDB, GT submitted a patent application for AT101 antibody (patent application number 102022000021546, Italian Ministry of Economic Development).